Fast forward to actionable results with rapid antimicrobial susceptibility testing Introducing the Q-linea ASTar®


System – fast and


comprehensive rapid AST, engineered for the most demanding clinical labs


Gaining early access to AST results for critically ill patients is key to optimizing treatment decisions and antimicrobial stewardship.


Within ≈ 6 hours, the fully automated ASTar System delivers accurate minimum inhibitory concentration (MIC) results direct from positive blood cultures, versus up to 72 hours with traditional methods*. And, it quickly processes up to 12 samples in parallel, with each sample requiring only two minutes of hands-on time.


Globally distributed by Thermo Fisher Scientific— learn more at thermofisher.com/ASTar and #fastforwardAST


*Workflow analysis performed by Q-linea at several European and US hospitals. Product is CE marked but not 510(k)-cleared and not available for sale in the U.S. Availability of product in each country depends on local regulatory marketing authorization status. © 2021 Thermo Fisher Scientific Inc. Q-linea AB is the legal manufacturer of ASTar® trademark of Q-linea AB. The ASTar system is distributed globally by Thermo Fisher Scientific.


. ASTar® is a


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57